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Summary 
Background: Prevalence of faecal incontinence is greater in patients with 
inflammatory bowel disease than in the general population. It is a major concern for 
patients with inflammatory bowel disease, even when disease is in remission. It is 
underreported and negatively affects quality of life.  
Aims: To explore the evidence on the associations of faecal incontinence in 
inflammatory bowel disease and the effectiveness of interventions. 
Methods: Databases searched in October 2017: Web of Science, MEDLINE, 
EMBASE, CINAHL, PsycINFO, British Nursing Index and Scopus. Manual search of 
reference lists was also conducted. Four researchers independently screened 
references and extracted data. 
Results: Eighteen studies were included in the review (14 on associations, four on 
interventions). Presence of faecal incontinence was reported as 12.7-76% among 
5924 participants, varying in definitions adopted and populations studied. Factors 
associated with faecal incontinence included disease activity, loose stool, female 
gender, childbirth, previous surgery, anal sphincter weakness or fatigability, anxiety 
and depression. The cross-sectional design of studies means causation cannot be 
inferred. Interventions included surgery (sphincter repair and sacral nerve stimulation) 
and tibial nerve stimulation which each improved faecal incontinence. However, the 
four intervention studies were small (34 participants in total) and uncontrolled.  
Conclusions: There is a high prevalence of faecal incontinence in inflammatory bowel 
disease, associated with various sociodemographic, clinical and psychosocial factors 
which could be targeted in future interventions. Future intervention studies with control 
    
3 
 
groups, targeting likely underlying causes such as disease activity, loose stool, 
psychological factors and anal sphincter function, are needed.  
Key words: inflammatory bowel disease, faecal incontinence, interventions, 
systematic review 
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INTRODUCTION 
Inflammatory bowel disease (IBD) mainly comprises Crohn’s disease (CD) and 
ulcerative colitis (UC). IBD causes relapsing-remitting gut inflammation and a number 
of debilitating symptoms including abdominal pain, fatigue, diarrhoea and urgency, 
with or without faecal incontinence (FI). 
FI is a distressing personal and social hygiene problem 1, 2. Individuals may be 
unaware of bowel leakage (passive soiling) or feel sudden urgency but be unable to 
reach a toilet in time (urge incontinence) 1. In the general population, 1-15% of adults 
experience FI 3 4 5. The prevalence is greater amongst those with IBD, however, 
definitional differences of ‘incontinence’ and selective study samples have resulted in 
varying prevalence reports. A systematic review has reported a pooled prevalence 
(from six studies) of 24% FI in people with IBD 6. This previous review focused on 
anorectal function rather than wider, potentially modifiable, associations.  
FI has a negative emotional and psychosocial impact and often leads to social isolation 
and poorer quality of life2. Fear of FI can be as restricting as the event itself in terms 
of daily and social functioning. Some IBD patients do not leave their homes for fear of 
experiencing FI 1. Despite bowel control being reported as one of the main concerns 
of patients with IBD, it remains a taboo subject between patients and physicians1, 7. Of 
IBD patients reporting FI, only 38% had sought help for the symptom and less than 
half of these felt satisfied with the help they received 8. Patients find FI embarrassing 
to discuss whilst clinicians avoid raising the issue due to limited knowledge on how to 
manage it 2. Understanding the factors associated with FI and reviewing the 
interventions available to manage this symptom should identify targets for future health 
interventions. 
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In the general population, management of FI focuses on a stepwise trial of 
conservative treatments, such as diet regulation, biofeedback or pelvic floor exercises, 
before proceeding to more invasive procedures, such as irrigation or surgery9, 10. 
These methods are often effective in non-IBD populations 11-13 but have not been 
reported in IBD. 
AIMS 
Review questions: 
• Which clinical and psychosocial factors are associated with the presence, 
frequency and severity of IBD-related FI?  
• What interventions have been used for the management of IBD-related FI and 
how effective are they? 
METHODS 
Protocol and registration  
The review was registered as a novel systematic review: 
http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017076928 
[published 21.09.17]. The review methods, objectives and eligibility criteria 
arespecified in detail in this protocol. 
 
 
Eligibility criteria 
Study inclusion and exclusion criteria were pre-specified (Online Supplementary Table 
1). We included people with IBD of any sub-type and all quantitative observational and 
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interventional designs. We excluded people with IBD and FI secondary to specific 
surgical procedures such as ileo-anal pouch formation as this has been reviewed 
elsewhere14 .  
 
 
Searches 
Databases were searched in October 2017: Web of Science [from 1900], MEDLINE 
[via OVID, from 1946], EMBASE [via OVID, from 1974], CINAHL [from 1996], 
PsycINFO [via OVID, from 2002], the British Nursing Index [from 1994] and Scopus 
[from 2004]. The reference lists of papers included were hand searched. 
The search strategy involved free-text and subject heading searching [MeSH terms] 
and was modified for each database. Search terms related to IBD [IBD, inflammatory 
bowel disease, Crohn’s disease, ulcerative colitis,] were combined with terms 
associated with FI [faecal/fecal incontinence, bowel incontinence, anal incontinence, 
accidental bowel leakage, defaecation/defecation, incontinence and continence] and 
terms related to factors [predictors, risks, factors, associations, causes, and 
relationship] and interventions [treatment, intervention, management, trial, therapy, 
and care].  
Study selection 
Studies identified in the search were exported to Endnote bibliographic software 
(EndNote7).  
The searches retrieved 2,820 records. After duplicates were removed, one author (HP) 
examined all article titles and abstracts, excluding irrelevant papers. The remaining 53 
papers and abstracts were read and 34 excluded; if there was doubt about eligibility, 
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consensus was reached by three authors (HP, CN, BK). . We attempted to contact 
authors for further details where only an abstract was found. As few full papers were 
retrieved, abstracts were included. Figure 1 shows the PRISMA flow diagram. 
Data extraction 
Data  were extracted onto an Excel spreadsheet. Missing data were, if possible, 
retrieved from the original researcher.  
QUALITY APPRAISAL  
Quality of papers was reviewed independently by at least two of the authors  using the 
appropriate Critical Appraisal Skills Programme (CASP) tool for each study design 15. 
Studies were classified as low, medium or high quality (Online Supplementary Table 
2). Any disagreement between reviewers about quality scores was resolved through 
discussion. 
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Figure 1. PRISMA flow diagram of citation retrieval and selection process. 
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Online Supplementary Table 2: Associations with faecal incontinence in IBD (by author) 
Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
Brochard 
[2017],  
France, 
cross-
sectional.  
173 women on a 
database of 
perianal CD 
patients 
(107/173, 62%, 
had history of 
anal fistula), with 
confirmed CD of 
childbearing age 
(15-45 years old). 
Median age 38.2 
years (IQR: 28.9-
45.6). 
 
113/173 parous 
(65%). 134/173 
(77%) reported 
treatment for CD.  
 
Questionnaires 
mailed to 327 
consecutive 
females referred. 
1. Cleveland Clinic 
Incontinence Score 
(CCIS) of ≥5. 
 
2. Obstetric outcomes: 
gestational age, date, 
number and term of 
birth, least and greatest 
birth weights, mode of 
delivery (Caesarean 
Section or vaginal), use 
of episiotomy, 
instrumental delivery 
(vacuum, forceps), 
vaginal tears (checked 
with hospital records); 
demographic and 
clinical characteristics of 
CD from hospital 
records: birth date, age 
at diagnosis, disease 
extent, perianal 
involvement and 
65/173, 37.5% (CI 30.7-45.0) reported CCIS 
≥5.  
40/173, 23.1%, (CI 17.5-29.9) had severe FI 
(CCIS ≥ 9). 
 
Factors associated with FI in whole cohort 
(multivariate analysis): disease duration 
(p=0.02); history of anal fistula surgery 
(p=0.008); number of childbirths per woman 
(p=0.02); Harvey Bradshaw index >4 
(p=0.0001); FI not associated with: age at 
IBD onset or age at most recent follow up 
(p=0.72); history of abdominal surgery 
(p=0.08); anal fistula at most recent follow-up 
(p=0.57); mode and characteristics of delivery 
(Caesarean Section vs. vaginal), instrumental 
delivery and experience of obstetric tears or 
episiotomy were not associated with FI (in 
univariate analyses, all p>0.05). Montreal 
classification not associated with FI in 
univariate analysis. 
 
Quality: 
Medium 
 
Some data 
(pregnancy and 
deliveries) 
collected 
retrospectively.  
 
Response rate 
56.3%. Patients 
recruited from a 
database of 
perianal CD 
patients at a 
tertiary referral 
centre - selection 
bias likely- may 
be increased 
prevalence of 
severe CD, and 
more likely to 
have perianal 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
56.3% (173) 
responded. 
Stoma and 
incomplete 
scores excluded  
(n = 11). 
disease behaviour 
(Montreal classification), 
history of anal or major 
abdominal surgery. 
In parous women FI associated with 
(multivariate analysis): abdominal surgery, 
anal fistula surgery and Harvey Bradshaw 
index >4 (p=0.0002). Not associated with 
number of childbirths or any other obstetric 
variable.  
 
Potential targets for intervention: disease 
activity 
lesions than CD 
generally.  
 
Multivariable 
analysis 
conducted.  
Duncan [2013], 
 
UK, cross-
sectional. 
 
380 people with 
IBD attending an 
outpatient clinic. 
40% UC, 60% 
CD. 47% female.  
Median age 38 
(IQR 31-50). 
 
1. Any episode of FI in 
previous 3 months. 
ICIQ-B. St Marks FI 
score.  
 
2. Disease activity 
67% reported FI in past 3 months.  
90% reported anal incontinence (FI + flatus 
incontinence).  
No difference in FI rates between CD and UC 
(p = 0.74).  
FI reported as strongly associated with 
current disease activity in CD (p<0.0001) but 
not in UC.  
37% reported FI during both flares and 
remission.  
 
Potential targets for intervention: disease 
activity in CD 
Quality: 
Abstract only.  
 
Author confirmed 
no further data 
available. Not 
clear if 
participants were 
consecutive or 
convenience 
sample.  
Flor [2014], 
Spain, cross-
sectional.  
 
“Random sample” 
of 340/1004 IBD 
patients over 18 
years attending 
an IBD clinic. No 
1. Cleveland Clinic 
Incontinence Score: cut-
off not stated. 
 
Overall FI 53.6% 
FI in 58.3% with UC. 
FI in 49.4% with CD. 
 
Quality: 
Abstract only. 
 
Unclear if truly a 
random sample, 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
details on gender 
or age. Survey 
administered by a 
gastroenterologist 
in person or by 
phone. 
 
334 of 340 
responded.  
2. Quality of life; stool 
consistency (unclear 
how measured; disease 
flare (unclear how 
measured).  
Associated with disease flares (64%) and 
liquid stools (90.5%), gastroenterological 
surgery and older age in UC. 
 
Not related to disease type (UC vs CD), sex.  
Quality of life worse with FI. 
 
 
Potential targets for intervention: disease 
activity, liquid stools. 
 
 
 
or a convenience 
sample as 
abstract also 
states “selected”.  
Gonzalez-Ortiz 
[2015],  
Mexico, cross-
sectional.  
 
96 with IBD.  
78 with UC: 54% 
female, mean 
age 43 years; 
56% pan-colitis; 
82% less than 2 
relapses per 
year, 5% with a 
pouch. 
18 with CD: 67% 
female, mean 
age 55 years. 
1. Cleveland Clinic 
Incontinence Score: cut-
off not stated. 
 
2. Harvey Bradshaw 
index for CD; Mayo 
score for UC.  
FI in 31% with UC: associated with disease 
activity (OR 7.5; p = 0.002). 
FI in 44% with CD: associated with 
inflammatory behaviour. 
 
 
 
Potential targets for intervention: disease 
activity 
Quality: 
Abstract only. 
 
Selection of 
participants and 
cut off for FI not 
stated. 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
Kangas, 
[1992],  
Finland, 
case-control. 
63 people with 
CD and 10 
controls. 
CD: 11/63 
partially 
incontinent, 3/63 
totally 
incontinent.  
1. Measure of FI not 
stated. 
 
2. Anorectal manometry. 
Diarrhoea (measure not 
stated). 
14/63 (22%) with CD had some FI.  
Incontinent patients had lower resting 
(p<0.01) and squeeze pressures (p<0.05) 
and different (? lower – not stated) rectal 
capacity than continent people with CD and 
controls.  
 
Potential targets for intervention: 
diarrhoea, anal resting and squeeze 
pressure, rectal capacity. 
 
 
 
 
 
 
 
 
 
Quality: 
Abstract only. 
Kanis [2015] 
Netherlands, 
cross-
sectional. 
 
343 women 
recruited through 
a patient 
organisation or 
social media.  
61.5% CD. 
Mean age 41.8 
years (SD 13). 
1. St. Mark’s 
Incontinence score 
(range 0-24). 
 
2. Online survey. 
24.0% never had FI.  
29.2% seldom had FI. 
29.8% sometimes had FI.   
8.9% weekly FI. 
8.1% daily FI.  
Median FI score 7 (IQ range 5-10). 
No difference between CD and UC. 
Quality: 
Abstract only 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
Median of 16 
years since last 
delivery.  
61 had perianal 
disease.  
51.2% 
nulliparous. 
40% had one or 
more vaginal 
deliveries.  
Univariable analysis: FI score higher if had a 
previous vaginal delivery (median 8 vs 7, 
p=0.02), but this relationship was lost in 
multivariable analysis controlling for perianal 
disease and menopause.  
FI score higher if postmenopausal (median 8 
vs 6, p=0.001).  
Postmenopausal: 66.1% FI; premenopausal 
45.9% FI (p = 0.03): childless women also 
increased FI prevalence post-menopausal.  
 
Potential target for intervention: 
menopause therapy? 
 
 
 
 
 
 
 
 
 
Keogh [2017], 
Ireland, cross-
sectional.  
250 IBD patients, 
tertiary care 
centre. 
117 completed 
the questionnaire 
1. International 
Consultation on 
Incontinence 
Questionnaire-IBD. 
 
77/117 (66%) reported any FI. 
46.1% of patients were in remission.  
 
30% FI episode in past 3 months. 
70% urgency in past 3 months.  
Quality:  
Medium 
 
Cut off used for 
anxiety and 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
(47% response 
rate) 
46 UC (39%); 71 
CD (61%). 
Female: 66 
(56%). 
Mean age 49 
(range not given). 
 
 
2. Hospital Anxiety and 
Depression Score 
(HADS); disease activity 
index (Harvey Bradshaw 
Index for CD; Walmsley 
Index for UC); 
demographic data; date 
of diagnosis. 
 
Overall: 52% reported anxiety, 31% 
depression. Anxiety significantly higher than 
depression (p<0.001). Anxiety (p<0.001) and 
depression (p<0.005) were significantly 
higher in patients with FI compared to those 
without FI.  
With FI, 65% reported anxiety; 41% 
depression. 
Without FI: 28% reported anxiety; 16% 
depression.  
 
No association between FI and age (p=0.69), 
gender (p=0.99), disease duration (p=0.72), 
disease type (CD or UC, p=0.71). No 
association found between levels of anxiety 
(p=0.43) or depression (p=0.07) experienced 
and disease duration. 58% reported that no 
health professional had addressed the topic 
of FI during consultations.  
 
 
 
Potential targets for intervention: anxiety, 
depression. 
 
depression 
unclear.  
No statistical test 
reported for 
relationship 
between disease 
activity and FI.  
 
No multivariable 
analysis. 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
Neill [2016], 
USA, cross-
sectional. 
37 CD patients, 
outpatient clinic. 
36 completed 
questionnaires 
(97.2% response 
rate). 
Male: 17 (47.2%) 
Female: 19 
(52.8%). Mean 
age 39.9 (range 
not given). 
Mean duration of 
disease 13.6 
years (range 1-34 
years) 
1. Crohn’s Disease 
Activity (CDAI). Faecal 
Incontinence Severity 
Index (FISI). 
 
2. Quality of Life; Short 
Quality of Life in 
Inflammatory Bowel 
Questionnaire (SIBDQ) 
and Medical Outcomes 
Short Form 12 (SF-12) 
  
CDAI and FIS were strongly associated with 
SF12 p <0.001 
 
Correlation Coefficients: SIBDQ and CDAI, -
0.79,  
SIBDQ and FISI, -0.53. 
 
 
 
 
Potential targets for intervention: None 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quality:  
Medium 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
 
 
 
Norton [2013], 
UK, cross-
sectional.  
10,000 members 
of a national 
Crohn's & Colitis 
Organisation, 
selected 
randomly by 
computer, sent a 
postal 
questionnaire;  
4,827 (48%) 
responses 
received; 3,264 
complete and 
without a stoma 
(32.6%) [1,599 
UC (49%); 1,543 
CD (47%)]; 126 
other IBD (4%); 6 
missing diagnosis 
(0.2%). 
67% female.  
Mean age 50.3 
years (range 19-
92). 
1. International 
Consultation on 
Incontinence 
Questionnaire-Bowels)  
 
2. Questionnaire 
developed by authors, 
including: 
demographics, IBD, 
medical, obstetric 
history, symptoms & 
perceptions of stress, 
anxiety, diet, other 
factors on FI; Bristol 
Stool Chart; urinary 
continence (ICIQ-UI); 
quality of life (IBDQ). 
Disease activity: Harvey 
Bradshaw Index (HBI) 
for CD; SCCI for UC.  
74% (CI 72-75%) of respondents reported 
some FI. For 9% this was regular. If all non-
responders are considered to have no FI, 
then 24% (CI 23-25%) of people with IBD 
have some FI; 3% regularly. 
 
Multivariable significant variables for 
presence of FI: age, peaking at 51-60 years 
(p = 0.05); female gender (OR 0.76 for males, 
p = 0.003); ileo-anal pouch (OR 2.53, p = 
0.04); anal fistula surgery (OR 1.75, p = 
0.007); anal fissure (OR 2.32, p = 0.03); 
abdominal surgery for IBD (OR 1.59, p 
<0.001) and urinary incontinence (OR 3.34, p 
<0.001). Vaginal delivery not significant after 
adjusting for effects of other variables.  
 
Multivariable significant variables for 
frequency of FI: all the above except pouch 
surgery. For CD, 1 unit HBI increase, 
increased risk of FI by 25% (p<0.001). For 
UC, 1 unit SCCI increase, increased FI risk 
by 28% (p<0.001).  
 
Quality: 
Medium 
 
Self-reported IBD 
with no 
verification of 
diagnosis. Poor 
response rate.  
 
Multivariable 
analysis 
conducted. 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
Looser stool associated with more regular FI 
(p<0.001), regular FI associated with flatus, 
poorer QoL and restricted social function vs 
rare/no FI (all p<0.001). 
 
Potential target for intervention: disease 
activity, loose stool, pelvic floor function 
(urinary incontinence) 
Ong [2007], 
UK, case-
control.  
777 regional 
members of a 
National Colitis 
and Crohn's 
Organisation; 
male members 
asked to 
complete the 
questionnaires on 
behalf of their 
unaffected female 
partner as a 
control group. 
 
491 (63%) 
responses. 477 
completed forms; 
346 women with 
IBD [153 UC 
1. Questionnaire 
developed by authors: 
symptoms of FI. 
Emphasis on time of 
onset of FI in relation to 
IBD diagnosis and 
childbirth mode of 
delivery. 
 
229/346 (66.2%) women with IBD parous; CD 
67%, UC 65%; 116/131 (88.5%) women 
without IBD parous.  
 
37/229 (16%) women with IBD had 
caesarean section (CS). 15/116 (13%) 
women without IBD had had CS (difference 
for CS rates: χ2=0.62, p = 0.62). 
 
Parous women with IBD: 58/229 (25%) 
reported FI; 62% attributed this to IBD, 28% 
dated this to time of vaginal delivery.  
Parous women without IBD: 6/116 (5.2%). 
2/116 (2%) reported FI dating to vaginal 
delivery. 
 
Potential target for intervention: mode of 
delivery? 
 
Quality:  
Low 
 
Subjective 
reporting of 
symptoms, timing 
and attributions.  
 
No multivariable 
analysis. 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
(32%); 193 CD 
(40%)] and 131 
female partners 
without IBD 
(27%). Age NR    
 
 
 
 
 
 
 
 
 
 
 
 
 
Papathanasop
oulos [2010, 
2013], Greece, 
case-control.  
72 total;  
58 consecutive 
patients with IBD 
at a tertiary 
centre: 20 UC; 38 
CD. 
14 healthy 
controls recruited 
via advert.  
 
Excluded: over 
70 years, 
significant co-
morbidities, 3 or 
more vaginal 
1. Faecal Incontinence 
Severity Scale (FISS) 
(self-reported). 
 
2. Perianal disease 
activity index (PDAI); 
Crohn's disease activity 
index (CDAI); Simple 
Clinical Colitis Activity 
Index (SCCI) for UC. 
Bristol Stool Chart; daily 
bowel diary. Oral 
glucocorticoid use; 
presence of proctitis; 
perianal disease.  
27/58 (47%) with IBD reported urgency. 13/58 
(22%) reported FI.  
 
Multivariable analysis: FISS associated with 
active disease (p = 0.033); anal sphincter 
fatigue rate index (p = 0.037); defects on 
ultrasound in the internal (but not external) 
anal sphincter (p =0.0008); rectal urge 
volume (p =0.009). Model explained 62% of 
variance (p < 0.0001).   
 
People with IBD and urgency had a more 
fatigable anal sphincter than people with IBD 
and no urgency than in healthy controls (p < 
0.001). 
Quality: 
Low 
 
Very similar or 
identical data 
presented in the 
two papers.  
 
Multivariable 
analysis 
conducted. 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
deliveries, current 
perianal sepsis.  
25/72 (34.7%) 
female. 
Mean age 42 
(IBD) /45 
(controls) years. 
 
Anorectal manometry to 
measure: external anal 
sphincter fatigability 
(fatigue rate; anal 
contractility (maximum 
squeeze time), and 
fatigue rate index; rectal 
compliance. Endoanal 
ultrasound to detect 
anal sphincter defects. 
 
 
 
 
 
 
FISS scores correlated with looser stool 
consistency and higher stool frequency. 
 
Fatigue rate index and rectal compliance 
were significantly different in IBD than in 
healthy controls.  
 
Potential target for intervention: disease 
activity; decrease fatigability of anal 
sphincter; improve rectal compliance; 
improve stool consistency and frequency.  
 
 
 
 
 
Rao [1988], 
UK, cross-
sectional. 
110 assessments 
carried out in 96 
patients with 
histological 
proven UC. 
60/96 active 
(endoscopically/hi
stologically); 
50/96 quiescent; 
twice during 
1. Symptom 
questionnaire: presence 
of FI (defined as the 
"inability to control 
defecation voluntarily 
resulting in leakage of 
motions and/or soiling of 
garments"). 
 
FI: 14/110 (13%) (12 women, 2 men) with 
active colitis reported FI (all except 2 were 
over 60 years of age). 
 
There was greater prevalence of FI in those 
with active UC than quiescent disease in both 
total and distal colitis (p<0.01). 
 
Patients with active disease exhibited higher 
prevalence of: urgency, incomplete 
Quality: 
Low 
 
No multivariable 
analysis. 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
active and 
quiescent 
periods, hence, 
110 
assessments. 
Female: 59/110 
(54%). 
Mean age 48 
(range 19-80).  
 
 
2. Presence/absence of:  
urgency (an urgent and 
irresistible desire to 
defecate); incomplete 
evacuation (strong, 
persistent desire to 
evacuate after 
defecation); tenesmus 
(continual inclination to 
evacuate bowels 
accompanied by painful 
straining); pain (lower 
abdominal or rectal 
pain, with or without any 
relation to defecation); 
perianal soreness 
(intense discomfort or 
itching of perianal skin; 
stool consistency (loose, 
formed or hard); night 
time defecation; 
average daily bowel 
frequency. 
evacuation, tenesmus, pain, anal soreness 
and FI compared with those with quiescent 
colitis. Prevalence of symptoms did not vary 
between total and distal disease.  
 
Potential target for intervention: disease 
activity 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subasinghe 
[2016], Sri 
Lanka, cross-
sectional.  
184 [153 UC 
(83%); 31 CD 
(17%)] 
1. St. Mark’s 
Incontinence score 
(range 0-24). 
 
48/184 (26%) reported FI. 10% of those with 
FI reported regular FI. 33% reported flatus 
incontinence. No association between FI and 
type of IBD. Significant association of FI with 
Quality:  
Medium 
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
IBD patients at a 
tertiary care 
hospital. 
101/184 (54.9%) 
female.  
Mean age 45 
(range 
20-78).  
 
 
 
 
2. Sociodemographic 
data, disease 
characteristics, 
management details 
and history; QoL (IBDQ-
32) 
 
age, gender and quality of life.  Females had 
significantly higher FI scores than males (79.9 
vs 79.34, p<0.05).  
Of those with FI, 70.8% were women.  
No significant difference between CD and UC 
in mean FI score (CD=14.45, UC=13.79, 
p=0.63) or bowel symptoms (CD=22.39, 
UC=21.11, p=0.22), social (CD=11.10, UC= 
11.91, p=0.3), systemic (CD=12, UC=12.46, 
p=0.56) and emotional symptoms (CD=34.77, 
UC=34.04, p=0.61). 
 
No difference in FI between those who had 
surgical or medical management of IBD.  
The extent of colitis was significantly 
associated with FI scores (p=0.002) - patients 
with distal colitis had higher scores.  
 
Association of total IBDQ and FI score was 
statistically significant (p<0.001). Weak 
association between FI and emotional and 
systemic QoL components (rs<0.3), moderate 
association between FI and social QoL 
(rs=0.3-0.7), strong association between FI 
and bowel-related QoL (rs>0.7). 
Potential target for intervention: disease 
activity (distal colitis) 
Main focus on 
determinants of 
quality of life. 
Some values 
quoted for score 
are outside the 
range possible 
(e.g. score of 79 
quoted for 
incontinence 
score when the 
maximum score 
possible is 24).  
 
No multivariable 
analysis.  
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Author, year, 
country, 
design  
Population 1.Faecal incontinence 
measure/definition 
 
2.Other 
measures/outcomes 
Main findings 
 
Potential targets for intervention 
Quality of study 
and comments 
Vollebregt 
[2017], 
Netherlands, 
cross-
sectional. 
Questionnaires 
sent to 528 CD 
patients between 
2003-2013. 
 
325 completed 
(62%). 
215/325 (66%) 
female. 
Median age 42 
years (range 19-
88). 
1. St Mark's 
incontinence score and 
Cleveland Clinic 
incontinence score. 
 
2. Obstetric history, 
current and past 
perianal disease, 
current perianal 
symptoms, presence of 
liquid stools, current 
symptoms of FI, impact 
of FI on QoL (Faecal 
Incontinence QoL 
questionnaire). 
65/325 (20%) reported FI for liquid/solid 
stools at least once in the last 4 weeks. 
29/325 (9%) reported gas incontinence only. 
 
Multivariate analysis: liquid stools (p<0.0001), 
stricturing disease behaviour (p=0.02) and 
perianal disease (p=0.03) were all 
significantly associated with IBD-FI. Age and 
diagnosis age lost association with IBD-FI.  
 
Those who reported FI more than weekly 
scored lower on all QoL scales (lifestyle, 
coping, depression, embarrassment) than 
those who reported FI less than weekly (all 
p<0.05). 
 
Potential target for intervention: liquid 
stools 
 
Quality: 
High 
 
Multivariable 
analysis 
performed. 
CCIS, Cleveland Clinic Incontinence Score; CD, Cohn’s disease; FI, faecal incontinence; IBD, inflammatory bowel disease; ICIQ-B, 
Incontinence Symptoms and Impact on Quality of Life; IBD-U, IBD unclassified; UC, ulcerative colitis; QoL, Quality of Life; IBDQ, 
inflammatory bowel disease questionnaire; NR, Not reported.  
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RESULTS  
A total of 18 studies reported in 19 papers were included. Two very similar papers 
apparently reporting the same participants were amalgamated 16, 17. Fourteen studies 
reported prevalence and associations of FI (summarised in Table 1, with more 
detailed data in Online Supplementary Table 2). There were a total of 5,924 
participants. Four studies tested interventions for FI with 34 participants (Table 2). 
Some focused only on female participants to determine the role of childbirth in IBD-
related FI 18, 19. Some reported both patients with UC and CD whilst others included 
either CD or UC patients alone. Some studies included IBD patients and a healthy 
control group whilst others consisted of IBD patients only. Quantitative synthesis 
such as meta-analysis was not appropriate due to the heterogeneity of the data, 
thus, a narrative review is presented.  
Presence and associations of FI in IBD 
Rates of FI varied from 12.7 to 76% across the 14 studies (Table 1). Various definitions 
of FI were used and response rates varied (Online Supplementary Table 2).  
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Table 1: Summary of prevalence and associations of faecal incontinence in IBD (by author, year) 
Author, year Number (%) 
respondents 
Percentage of 
participants 
reporting FI 
Definition of FI to be 
counted as experiencing 
FI 
Associations 
Brochard [2017]  173 (56.3%) 37.5% Cleveland Clinic Score ≥ 5 Disease activity; parity; mode of delivery; 
surgery 
  
Duncan [2013] 380 (% NR) 67% Any episode in previous 3 
months 
Disease Activity in CD only 
 
Flor [2014] 334 (98.2%) 53.6% Not stated Disease activity in CD only; loose/ liquid 
stools  
  
Gonzalez-Ortiz 
[2015] 
96 (% NR) 31-44% Cleveland Clinic Score: cut 
off not stated 
Disease activity; surgery 
 
Kangas [1992] 63 (% NR) 22.2% Not stated Loose/ liquid stools; anal sphincter structure 
or function 
Kanis [2015] 343 (% NR) 76% Any FI Post-menopausal 
Keogh [2017] 117 (47%) 66% Any FI Anxiety; depression 
Neill [2016] 36 (97.2%) 20.4%  Faecal Incontinence 
Severity Index (FISI). 
Disease activity; PCS & MCS domains of SF-
36 
Norton [2013] 3264 (32.6%) 74% Any FI Disease activity; age; gender; surgery; loose/ 
liquid stools; anal sphincter structure or 
function 
Ong [2007] 491 (63%) 25% parous 
women 
Any soiling or wearing a pad None reported 
Papathanasopoulos 
[2010, 2013] 
58 (100%) 22.4% FI in last 3 months Disease activity; loose/ liquid stools; anal 
sphincter structure or function 
 
Rao [1988] 96 (% NR) 12.7% Any FI Disease activity 
Subasinghe [2016] 184 (% NR) 26% Any FI Disease activity; age; gender; surgery  
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Vollebregt [2017] 325 (62%) 20% FI at least once in past 4 
weeks 
Loose/ liquid stools 
 
                  Total  5960    
Key: FI, faecal incontinence; NR, not reported; CD, Crohn’s disease; PCS, Physical Component Summary; MCS, Mental 
Component Summary; SF-36, Short Form 36. 
Note: further details of the studies, their method, results and quality appraisal are given in Online Supplementary Table 2.  
 
Table 2: Interventions for faecal incontinence in IBD (by author) 
Author, 
year, 
country, 
design 
Population Intervention Faecal incontinence measure and 
outcomes of intervention 
Quality of study 
and comments 
Alvarez 
[2011], 
Spain, 
cohort 
study  
10 patients with CD. 
3/10 female; mean age 
37 years (range 21-53) 
and complex perianal 
fistula and an anal 
sphincter defect; FI to 
solid stool. Mean of 3 
previous fistula 
procedures (range 1-
10).  
Induction therapy with 
Infliximab 5mg/kg at weeks 
0, 2 and 6. Then surgical 
repair of sphincter; fistula 
also cored out and seton 
inserted for 3 patients. 
Infliximab continued each 
8 weeks and azathioprine 
2.5mg for at least 6 
months. 2 patients delayed 
surgery until proctitis 
settled on drug regimen. 
Antibiotics for 7 days post-
operatively. No covering 
stoma. Seton removed 
Measures: Cleveland Clinic Incontinence 
Score (CCIS); other continence 
symptoms.  
 
Outcomes: CCIS score improved from 
18.0 (baseline) to 10.0 post-operatively 
(p= 0.003) and 9.3 at 48 months (p= 
0.001). Results appeared worse if 
urgency was present pre-operatively 
(p=0.003). 6/10 fully continent; 3/10 FI for 
liquid stool; 1/10 incontinent of flatus. 
7/10 reported improved quality of life. No 
difference between patients who 
continued or discontinued Infliximab. All 
patients reported that they would repeat 
the procedure again.  
Quality:  
High 
 
Variable disease 
course post-
operatively: 7/10 
had change in 
drug regimen over 
time. 
No control group.   
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Author, 
year, 
country, 
design 
Population Intervention Faecal incontinence measure and 
outcomes of intervention 
Quality of study 
and comments 
after 2 post-operative 
infliximab doses.   
3/10 had postoperative complications 
with one delayed healing (5 months) and 
2 abscess and recurrent fistulae. 
Vitton 
[2009], 
France, 
cohort 
study  
12 patients with IBD (7 
CD, 3 UC, 2 IBD-U; 
9/12 female. Median 
age 51 years (range 29-
64). 9/12 previous 
abdominal surgery; 6/12 
with anal fistula. FI 
reported for 6-240 
months, median 59 
months. Median 
continence score 13.5 
at baseline.   
Transcutaneous posterior 
tibial nerve stimulation 20 
minutes daily for 3 months: 
self-administered via 
TENS machine at home. 
Stimulation at 10Hz, 200 
µs, 10-30 mA, set at just 
below sensory threshold 
Measures: Cleveland Clinic Incontinence 
Score (CCIS); 0-5 VAS: 0-100 QoL scale.  
 
Outcomes at 3 months: CCIS: Improved 
in 4; unchanged in 6; worse in one. VAS 
improved in 5/12 (42%); QoL also 
improved in these 5, who all continued 
treatment after the study.  
3 patients reported greater time to defer 
defecation.   
Quality:  
Low 
 
Text reports only 
1/12 improved on 
CCIS; Table 
reports 4 improved 
this score. 
Methods describe 
statistical tests but 
no results are 
presented.  
No control group.  
Vitton 
[2008], 
France, 
cohort 
study  
5 patients with CD. 3/5 
female. Median age 48 
years (range 27-67). 
Perineal lesions with 
internal and external 
anal sphincter defects 
and CCIS >5/20.  
Sacral nerve stimulation: 
temporary for 3 weeks 
then permanent implant.  
Measures: Cleveland Clinic Incontinence 
Score (CCIS). Number of daily stools. 
VAS QoL.  
 
Outcomes (at median 14 months, range 
3-36 months):  no figures given but CCIS 
reported to have decreased by at least 
50%, number of stools and episodes of FI 
(all p<0.05). QoL also reported to have 
improved by over 50%. 
Quality:  
Low 
 
No figures 
reported for any of 
the outcome 
measures.  
 
No control group. 
 
Unclear if some 
patients had 
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Author, 
year, 
country, 
design 
Population Intervention Faecal incontinence measure and 
outcomes of intervention 
Quality of study 
and comments 
temporary 
stimulator only and 
were excluded.  
Scott 
[1989], 
UK, 
cohort 
study 
7 patients with anorectal 
CD. 6 reported as one 
lost to follow up. 5/6 
female. Age 12-48 
years. All with previous 
perianal surgery (3 
abscess, 3 fistula) + 1 
obstetric trauma as well. 
All with colonic 
resection.  
Overlapping anal sphincter 
repair (1 + rectopexy & 
hemicolectomy; 1 + 
closure of rectovaginal 
fistula); 5 with covering 
stoma (closed 2-20 months 
post operatively).  
Measures: FI measure not specified. 
Unclear how FI was assessed (clinician 
recorded in medical notes?) 
 
One wound breakdown at 16 days, re-
repair, persisting FI and permanent 
colostomy.  
 
5/6 reported as fully continent at mean of 
7.8 years (range 1.5-16 years).   
Quality:  
Low 
 
No control group. 
Unclear how 
patients were 
selected and if this 
is a complete 
series.  
 
No information on 
how outcomes 
were assessed. 
Abbreviations: CCIS = Cleveland Clinic Incontinence Score, CD = Cohn’s disease, FI = faecal incontinence, IBD = 
inflammatory bowel disease, IBD-U= IBD unclassified, UC = ulcerative colitis, QoL = Quality of Life. VAS = visual analogue 
scale. 
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Associations of FI in IBD: targets for health interventions  
Disease Activity 
A significant positive association between FI and IBD disease activity measured by a 
disease activity index (DAI) was found in all but one study which measured this 20. 
Active disease was significantly associated with the presence 2, 16, 18, 21 and the 
severity of FI 16.  However, when using the inflammatory biomarker C-reactive 
protein (CRP), the relationship between disease activity and FI was not significant 16. 
Other studies found that FI persisted in remission and was also present in those with 
low DAI scores, suggesting that FI is not always associated with active disease 2, 20.  
Stool consistency  
Self-rated loose stools 2, 17, 22 were associated with more frequent 2, 22 and severe 
FI17 .  
Anorectal physiology and pelvic floor function 
FI severity scoreswere positively associated with lower rectal urge volume 17 , lower 
mean anal resting pressure 17 and a more fatigable anal sphincter compared to 
controls 16. A significant association was found between FI severity and internal and 
external anal sphincter defects, as detected by endoanal ultrasound 16.  
Anxiety, depression and fear 
Significantly higher levels of anxiety and depression were found in those with FI 
compared with continent people 20. Fifty-eight percent of participants reported 
anxiety and stress worsened FI symptoms 2. Patients who experienced FI more 
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frequently were more likely to ruminate about possible future FI occurrences and 
were negatively affected by such thoughts 2. Sixty-seven percent who had not 
experienced FI reported thinking about possible future FI, suggesting that FI-related 
anxiety is not necessarily associated with previous FI experiences 2. Parous women 
with IBD feared the possibility of postpartum FI 19. 
Associations with FI not amenable to interventions 
The review also identified associations between FI and IBD which are unlikely to be 
modifiable.  
Duration and type of IBD  
No significant association was found between disease type (CD or UC) and the 
presence of FI 2, 17, 20, 23. Patients with UC had increased risk of more frequent FI 
than CD patients 2. In CD FI was found more likely to occur in patients with stricturing 
or perianal disease than in those without 22. Patients with distal colitis had higher FI 
scores than those with total colitis 23. Others found that this difference was non-
significant 21. Patients with a longer disease duration were at greater risk of FI 18. 
This relationship was non-significant in another study 20. 
Age 
There were mixed findings on age and FI. Some studies found that older patients 
reported more FI 18, 22, or more frequently2. However, this was not found in other 
studies.20. In univariate analysis, a significant association was found between age 
and prevalence 18, 22 and frequency 2 of FI: younger individuals had lower prevalence 
and less frequent FI. This finding was not significant in other univariate 20 and 
multivariate analyses 18, 22. FI frequency was positively associated with age in 
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multivariate analysis 2. Age was only significantly associated with FI prevalence in 
patients with CD where FI was most prevalent in 51-60 year olds and the 81+ age 
group and not associated in those with UC 2. Age at diagnosis was not associated 
with FI in multivariate analyses 22. 
Gender 
Female gender was significantly associated with the prevalence and frequency of FI 
2, 23. This association was found in multivariate analysis for FI frequency and a 
significant association between female gender and FI prevalence remained in CD 
but not in UC  2. This was not found in other studies 20. Gender may be confounded 
by childbirth and being post-menopausal 24.  
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Childbirth 
Findings on obstetric factors associated with FI were mixed, including number of 
childbirths; mode of delivery (vaginal, assisted or caesarean section); episiotomy and 
other complications (such as breech birth and forceps delivery) 2, 18, 19. The number 
of childbirths was associated with the presence of FI 18.  Vaginal delivery increased 
the risk of FI 2, 19 by more than 50% compared with caesarean section 2. This was 
not found in all studies 18 and was not significant in multivariate analysis 2. Obstetric 
complications including perineal tears, episiotomy and instrumental delivery did not 
significantly increase the risk of FI 2, 18. Eighty-eight percent of those who attributed 
their FI to vaginal delivery had experienced episiotomy 19. However, this was a 
patient-reported, retrospective attribution, without objective clinical assessment.  
Surgery 
A history of abdominal and anal surgery was associated with FI 2, 18, 22.  This included 
anal fistula 2, 18, colorectal surgery, total/partial colectomy, previous colostomy, anal 
fissure, anal stretch, ileo-anal pouch, small bowel surgery and bowel resections 2, 22. 
Others found non-significant associations between FI and previous surgeries 
including anal surgery 17, anal fistula and ileo-anal pouch surgery.  
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Interventions for FI in IBD 
Four small cohort intervention studies which addressed FI in IBD were found 25-28, 
with a total of 34 participants (Table 2). These studies involved anal sphincter repair 
surgery 27, 28, sacral nerve stimulation 26 and transcutaneous posterior tibial nerve 
stimulation (TPTNS) 25. In all but one study 25, patients had FI secondary to perianal 
disease. All studies reported improvements in FI post-treatment. However, only 42% 
of patients reported reduced FI after 3 months of TPTNS treatment 25. In two studies, 
FI improvements were accompanied by improved faecal urgency 26, decreased need 
to defecate 26, increased retention time 25, 26 and more solid stool consistency.26 Two 
studies reported improved quality of life after treatment 25, 26.  
 
DISCUSSION 
Fourteen studies that explored correlates of FI in IBD and four that tested 
interventions for FI were analysed. Overall, there is a lack of robust evidence on both 
the mechanism and associations of FI in IBD and, in particular, the effectiveness of 
interventions. This contrasts with FI in the general population, where there more 
literature 10.  
The recent review which reported a pooled prevalence from six studies of 24% FI in 
IBD 6, as in the present review, found that most studies were of clinic attenders or 
members of a patient organisation and so may be a biased sample.  Studies of 
anorectal function in IBD and FI have not reported a consistent pattern of 
association, except FI being associated with anal sphincter defects 6. 
We have identified that few potential targets for interventions have been tried. 
Disease activity and loose or liquid stool would appear to be the most obvious 
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factors which could potentially be changed. Other targets have not been robustly 
investigated. In some studies, active disease was predictive of the presence 2, 16, 18, 
21, 29 and severity of FI 16. Others found that patients with less active disease still 
experienced FI, suggesting that FI is not always the result of active disease 2, 20.  
Disease activity indices correlate poorly with objective markers of disease activity 30. 
When using C-reactive protein to determine disease activity, no significant 
association was found with FI16. C-reactive protein has been reported as an 
insensitive biomarker of endoscopic inflammation as it is altered by infections non-
specific to IBD16. Future studies should employ more robust biomarkers of active 
disease 18.  
It is unclear why IBD patients continue to experience FI when in remission. It may be 
the result of rectal scarring (fibrosis). Alternatively, psychosocial factors may have a 
perpetuating role in FI in periods of remission.2, 20 Anxiety and depression levels 
were significantly higher in patients who had previously experienced FI compared 
with those who had not.20 However, it is difficult to establish causality within this 
finding.  Over half of patients reported that anxiety and stress exacerbated FI.2 All 
patients who experienced FI reported worrying about possible future accidents.2 Yet, 
over 60% of those who had never experienced FI reported similar concerns.2 This 
suggests that the possibility of future FI may be anxiety-provoking for patients with 
IBD regardless of previous FI experiences.  
Some associations are not amenable to modification.  The relationship between age 
and FI may be confounded by other factors, such as increased likelihood of anal 
surgery and longer disease history in older patients.2 Some found FI more commonly 
in females than males 2, 23 possibly confounded by childbirth.2 
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The relationship between FI and obstetric factors was inconsistent. Brochard and 
colleagues 18 challenged others’ findings that vaginal delivery increased the risk of FI 
compared with caesarean section. This lack of relationship between FI and childbirth 
is also found in the general population 5. 
Different factors may be associated with the occurrence of FI in UC and CD patients. 
Whilst there was no significant difference in the prevalence of FI between IBD 
diagnoses 2, 16, 20, 23, UC patients experienced more frequent FI than CD patients 2. 
The differences between UC and CD in FI should be explored further to ensure 
appropriate management of FI in the two conditions.  
Some studies found that previous abdominal and anal surgery for IBD increased 
patients’ likelihood of experiencing FI 2, 18, 22, 31. Others found that this relationship 
was non-significant2, 17, 32, 33.  Knowing which surgical procedures in which patients 
carry greater risks of subsequent FI and may enable formulation of more effective 
informed consent and treatment plans for patients who are more susceptible to FI. 
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We propose some possible targets for FI management intervention based on this 
review in Figure 2. 
 
  Figure 2. Possible targets for health interventions for IBD-related FI 
Many intervention studies have been conducted for FI generally 10. However, most 
have specifically excluded participants with IBD. Only four studies tested interventions 
for FI in IBD. This is remarkably few studies given the high prevalence and heavy 
burden of FI in IBD. There is an ongoing study34 in which a nurse-led behavioural 
intervention for IBD-related FI is being tested; the results are not reported. All 
intervention studies had small samples, short follow-up, selective patient groups and 
possible placebo effects.  
Anxiety, depression and fear are associated with FI and may exacerbate this 
symptom, even during remission.2, 20. There is no research directly targeting the 
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psychological correlates of FI. More holistic approaches to targeting FI-specific anxiety 
in IBD patients could be considered. There is evidence of benefit of cognitive-
behavioural therapy (CBT) for other gastrointestinal disorders which exhibit FI and 
urgency, such as irritable bowel syndrome (IBS) 35,;  it is plausible that CBT could help 
in IBD. Techniques such as biofeedback and pelvic floor exercises used for FI in the 
general population11 might also help.  
LIMITATIONS 
The findings of the review should be considered in light of limitations.Six different 
measures of FI were utilised, with varying cut-offs 36-41 and lack of validation in an 
IBD population.  
Whilst some studies conducted rigorous measures to determine patients’ IBD 
diagnosis 16-18, 21-23, 33, others did not2, 19, 29. Others did not report how diagnosis was 
ascertained 20, 31, 32, 42-44. This is important to assess because IBD shares similar 
symptom complaints with IBS.45 
Most studies on associations of FI only conducted a univariable analysis. Future 
studies should recruit a sufficient sample to allow multivariable analysis, allowing 
more robust conclusions on associations.  
Participants were recruited from either an IBD organisation2, 19 or a tertiary referral 
centre.16-18, 20, 23, 29, with likely sampling bias in both of these subpopulations, 
individuals who experienced FI may have been more likely to participate, thus 
overestimating the prevalence of FI in IBD.2 Patients from a referral centre may have 
more severe IBD. Some studies did not report recruitment sources 21, 33;  others 
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recruited extremely selective samples 22, 31, 32, 42-44. Many studies used cross-
sectional designs limiting causal inferences 2, 18, 20-23, 29.  
 
RECOMMENDATIONS FOR CLINICAL PRACTICE 
Clinicians need to ask actively about FI 9  as patients may be reluctant to discuss this 
symptom 8. There should be no assumption that FI will always resolve when IBD is in 
remission. First line intervention for FI in IBD will be to manage active disease, likely 
using disease-modifying medication. If FI is not resolved when IBD is in remission or 
if stool remains loose, anti-diarrhoeal medication or dietary modifications to firm up 
the stool should be considered. Pelvic floor exercises,  urge resistance techniques, 
possibly biofeedback and practical advice on managing FI may be helpful.9 
Clinicians should also consider whether referral for psychological support or 
intervention is warranted.  
CONCLUSIONS 
This systematic review has highlighted various sociodemographic, clinical, and 
psychosocial factors associated with IBD-related FI. and highlights the need for further 
longitudinal studies with larger, representative samples and more extensive 
psychosocial measures. Only when the factors associated with FI in IBD are 
established can we develop effective interventions for this debilitating symptom. 
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Online Supplementary Table 1 
CD, Crohn’s disease; FI, faecal incontinence; IBD, inflammatory bowel disease; IBD-U, 
inflammatory bowel disease-unclassified; RCTs, randomised controlled trials; UC, Ulcerative 
colitis.  
Table 1. Inclusion and exclusion criteria for studies in the review 
 Inclusion criteria Exclusion criteria 
Population - Individuals of any age with any 
type of IBD (CD, UC or IBD-U). 
- Individuals with IBD who may also 
have a perianal fistula or an ileo-
anal pouch. 
 
- Individuals without IBD (unless 
as a control group). 
- Individuals who experience FI 
not related to IBD (unless as a 
control group). 
- Individuals who do not 
experience FI (unless as a control 
group). 
- Individuals with IBD who have a 
stoma. 
- Individuals with FI secondary to 
specific surgical procedures (e.g. 
ileo-anal pouch or anal fistula 
surgery).  
For intervention review: 
Intervention/Exposure 
- Any intervention approach or 
management strategy for FI 
(conservative and/or surgical). 
 
Comparator for 
associations 
 
 
 
 
 
 
 
 
Comparator for 
interventions 
- No comparison/control group. 
- Healthy individuals (without IBD 
and without FI). 
- Individuals with FI but not IBD. 
- Individuals with other 
gastrointestinal disorders (e.g. 
Irritable Bowel Syndrome) where 
results are analysed in comparison 
with IBD patients’ results. 
 
- No comparator or any other 
intervention. 
 
Outcome for 
associations 
 
 
 
 
 
Outcome for 
interventions 
- Factors associated with FI in IBD 
examined as a primary or 
secondary outcome (including 
sociodemographic, clinical, and/or 
psychosocial factors). 
 
-  FI frequency or severity measured 
by any means. 
- Quality of life. 
- Presence of FI measured but no 
associations explored.  
 
 
 
 
- Interventions in people with IBD 
but no measure of FI. 
Study design - Experimental studies (RCTs, 
quasi-experimental RCTs, non-
RCTs, pilot & feasibility studies). 
- Quantitative studies (case control, 
cohort, cross-sectional, longitudinal) 
- Qualitative studies 
- Case studies 
- Reviews 
- Editorials and letters. 
- Non-English language studies. 
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